With unique perspective from the COVID-19 pandemic, this expert panel will discuss the effective use of telehealth and remote patient monitoring (RPM) to manage patient and population health. Topics will include:

  • Telehealth and RPM: Overlap and differences
  • Acceptance of telehealth and RPM technologies among patients, providers, and healthcare organizations
  • What clinical data and real-world evidence tell us about RPM’s effectiveness
  • Promising applications of RPM in managing chronic disease
  • Feasibility of bringing telehealth and RPM to hospitals and other care settings across the U.S.
  • Addressing disparities: Potential for telehealth and RPM in rural areas and among the elderly and working poor

Representing healthcare, business, government, and academia, the panel will address current telehealth and RPM insights relevant to:

  • Healthcare executives
  • CIOs and other senior IT leaders in healthcare
  • Health information professionals
  • Clinicians
  • Medical directors
  • Anyone in hospitals, health systems, payer organizations, government, and NGOs interested in applications of telehealth and RPM in patient care

Featured Speakers

Russ Johannesson

CEO

Glooko Inc.

With 30 years of healthcare and technology experience, Russ Johannesson is Chief Executive Officer at Glooko, where he leads the Company’s corporate strategy and global expansion. He is also a member of the Company’s Board of Directors.

Mr. Johannesson is passionate about Glooko’s mission to improve the lives of people with chronic conditions by connecting them with their caregivers and equipping both with digital health technology for improved outcomes. He is establishing Glooko as the leading provider of remote patient monitoring, digital therapeutics and data management platforms in diabetes and related chronic conditions.

Prior to Glooko, he served as the Chief Operating Officer of Sharecare, where he helped drive overall corporate strategy and growth. Before his role at Sharecare, he served as the Chief Client Officer of OptumHealth where he was responsible for all sales, marketing, client management, support, implementation and growth operations for the $8.1B+ business. Mr. Johannesson holds an MBA from the University of Chicago Booth School of Business.

Tufia Haddad, MD

Chair of Practice Innovation and Platform

The Mayo Clinic

Dr. Tufia Haddad is an Associate Professor of Oncology at the Mayo Clinic College of Medicine and Science, and a Consultant in the Department of Oncology. Her clinical practice is dedicated to breast cancer. She serves as the Medical Director of Care Anyplace for the Mayo Clinic Center for Digital Health, a portfolio of services inclusive of enterprise-wide Remote Patient Monitoring, Advanced Care at Home, and Remote Diagnostics. She is an Associate Director of the Mayo Clinic Cancer Center Practice and Chair of Practice Innovation and Platform. She is a member of the Mayo Clinic Informatics/Artificial Intelligence Bioethics Advisory Council. As an oncologist and clinical investigator, she is an active member of the Mayo Clinic Cancer Center, Women’s Cancer Research Program, and she has received federal funding in support of biomarker discovery and early phase clinical trials in drug-resistant breast cancer. In the field of digital health, her interest is in the transformation of healthcare delivery models and development of advanced clinical decision support systems with novel connected health and AI technology solutions.  Dr. Haddad has authored over 70 peer-reviewed manuscripts, book chapters, and editorials.

Amy Abernethy, MD, PhD

President of Clinical Studies Platforms

Verily

Amy P. Abernethy, MD, PhD is the President of Clinical Studies Platforms at Alphabet’s Verily, where she has responsibility for the company’s Baseline program and other initiatives to support clinical trials and real-world evidence (RWE) studies.

Before joining Verily, Dr. Abernethy was Principal Deputy Commissioner and Acting Chief Information Officer of the US Food & Drug Administration. Prior roles include serving as CMO/CSO of Flatiron Health and multiple roles at Duke University, where she was Professor of Medicine.

Dr. Abernethy went to the University of Pennsylvania and then Duke University Medical School, and received her PhD from Flinders University in Australia.

Professor Carri W. Chan, PhD

Professor, Division of Decision, Risk, and Operations
Faculty Director, Healthcare and Pharmaceutical Management Program

Columbia Business School

Carri W. Chan is a Professor in the Division of Decision, Risk, and Operations and the Faculty Director of the Healthcare and Pharmaceutical Management Program at Columbia Business School. Her research combines statistical methods with mathematical modeling to develop -driven approaches to improving healthcare delivery. She has collaborated with providers from Kaiser Permanente, New York Presbyterian, Montefiore Medical Center, among others. She received her BS in Electrical Engineering from MIT and MS and PhD in Electrical Engineering from Stanford University.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.